MedTrace Logo

A Longitudinal Study of Colorectal Cancer Patients With Metastatic Disease in Middle-Norway

NCT02395224 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 354

Last updated 2022-02-14

No results posted yet for this study

Summary

The main objective is to provide original research results that may change clinical practice related to metastatic colorectal cancer. The study will evaluate treatment and patient care at different stages of the disease trajectory and the use of health care for this large group of patients. It will be possible to compare the effectiveness of chemotherapy, radiotherapy and symptomatic treatment given to "real life" patients with the efficacy reported in randomised clinical trials. By using longitudinal information on imaging, biomarkers, clinical staging and place of care it will be possible to improve patient classification at various stages of the disease. Based on this, a more appropriate, individualized treatment for colorectal cancer may be recommended during the phases of the disease trajectory. Participation in this project will not influence the treatment for colorectal cancer. All patients will be treated and followed-up according to current regional and national guidelines.

Conditions

  • Neoplasms, Colorectal
  • Neoplasm Metastasis

Interventions

OTHER

cancer treatment and follow-up according to current regional and national guidelines

Sponsors & Collaborators

  • Helse Midt-Norge

    collaborator OTHER

  • Norwegian University of Science and Technology

    lead OTHER

Principal Investigators

  • Stein Kaasa, MD PhD · Norwegian University of Science and Technology

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2023-01-15
Completion
2023-01-15

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02395224 on ClinicalTrials.gov